fisetin dacarbazine biological replicate 2
isolate
Established (commercially available)cell line derived from a skin primary melanoma
age
age 54
biomaterial_provider
ATCC, CRL-1619
sex
female
tissue
skin
cell_line
A375
disease
malignant melanoma
treatment
treated with fisetin and dacarbazine biological replicate 2
BioSampleModel
Human